MINNEAPOLIS -- Chosen for nearly one out of every two endovascular abdominal aortic aneurysm (AAA) repairs worldwide, the Endurant II AAA stent graft system from Medtronic, Inc. continues to ...
Leading medical devices player, Medtronic (NYSE:MDT - News) announced the receipt of CE Mark followed by the launch of Endurant II AAA stent graft system in the international market. The launch of ...
Global Market-Leader in Medical Technology for Endovascular Aortic Repair Also Receives 510(k) Clearance for Sentrant Introducer Sheath Medtronic, Inc. is expanding its market-leading portfolio of ...
New Data from the Global ENGAGE Registry Builds on Durability of Endurant, with Strong Outcomes Out to Four Years in Patients with Standard and Hostile Neck Anatomies Created with the collaboration of ...
New Bifurcated Component Leverages Proven Design of Predicate Device and Expands Anatomical Customization Options for Endovascular Repair of Abdominal Aortic Aneurysms The new device joins the ...
Medtronic Inc. (NYSE: MDT) today announced the CE (Conformité Européenne) mark and international launch of the Endurant ® II AAA Stent Graft System, which meaningfully expands the options physicians ...
Leading medical devices player, Medtronic ( MDT) announced the receipt of CE Mark followed by the launch of Endurant II AAA stent graft system in the international market. The launch of this device ...
Leading medical devices player ,Medtronic ( MDT) has strengthened its Endovascular portfolio with the US launch of Endurant II, the next generation AAA stent graft system, subsequent to its approval ...
New Data from the Global ENGAGE Registry Builds on Durability of Endurant, with Strong Outcomes Out to Four Years in Patients with Standard and Hostile Neck Anatomies DUBLIN - Nov. 15, 2016 - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results